Journals / Gülhane Tıp Dergisi / 2015 / Cilt: 57 - Sayı: 3

Anaesthetic management of patients with parkinson's disease undergoing mitral valve replacement surgery - enteral l-dopa administration: A case report and literature review.

Mitral kapak replasmanı yapılan parkinsonlu hastada anestezi yönetimimiz- enteral l-dopa uygulaması: Olgu sunumu ve literatürlerin incelenmesi

Pages
302–305
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The current literatures were reviewed and appropriate anesthesia management was achieved, the patient was discharged on the seventh postoperative day without any problem.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Anaesthetic management of patients with parkinson's disease undergoing mitral valve replacement surgery - enteral l-dopa administration: A case report and literature review.Parkinson disease is a neurodegenerative disorder common in the elderly.
📊
Key Findings & Data:Although these patients have been operated several times, few case reports are available regarding optimal anesthetic management of patients with Parkinson's disease.
💡
Conclusion & Impact:The current literatures were reviewed and appropriate anesthesia management was achieved, the patient was discharged on the seventh postoperative day without any problem.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Anaesthetic management of patients with parkinson's disease undergoing mitral valve replacement surgery - enteral l-dopa administration: A case report and literature review.Parkinson disease is a neurodegenerative disorder common in the elderly. Although these patients have been operated several times, few case reports are available regarding optimal anesthetic management of patients with Parkinson's disease. Discontinuation of anti-parkinsonian drugs used before surgery and effects of using anesthetic agents often increase severity of disease, morbidity and mortality. We aimed to present the anesthetic management of mitral valve replacement surgery for 79-year-old patient with Parkinson disease who has been medicated for 10 years. Anti-parkinson drugs were given enterally during the perioperative period. The current literatures were reviewed and appropriate anesthesia management was achieved, the patient was discharged on the seventh postoperative day without any problem.

Özet

Parkinson hastalığı, yaşlılarda yaygın görülen nörodejeneratif bir bozukluktur. Parkinson hastaları sık ameliyat olmasına rağmen bu hastalarının optimal anestezi yönetimini sağlayacak olgu sunumu sayısı azdır. Ameliyat öncesi kullanılan antiparkinson ilaçlara ara verilmesi sonucu ve kullanılan anestezik ajanların etkilerine bağlı olarak çoğu zaman hastalık şiddeti, morbidite ve mortalite artmaktadır. Bu yazımızda, 10 yıldır Parkinson tedavisi gören 79 yaşındaki hastamıza mitral kapak replasmanı ameliyatında uyguladığımız anestezi yönetimimizi sunmayı amaçladık. Perioperatif süre boyunca anti-parkinson ilaçlar enteral yolla verildi. Mevcut literatürler gözden geçirilerek uygun anestezi yönetimi sağlandı, postoperatif yedinci gün hasta sorunsuz şekilde taburcu edildi.

🔖

Cite This Article

EŞKİN, M. B., YILDIRIM, V., KURT, E. (2015). Anaesthetic management of patients with parkinson's disease undergoing mitral valve replacement surgery - enteral l-dopa administration: A case report and literature review.. Gülhane Tıp Dergisi, Cilt: 57 - Sayı: 3, 302–305. https://ajindex.com/articles/204973

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Brotchie J, Fitzer-Attas C. Mechanisms compensating for dopamine loss in early Parkinson disease. Neurology. 2009; 72(7):32-38.
  2. Van Den Eeden SK, Tanner CM, Bernstein AL at all. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003; 1;157(11):1015- 22. Torun Ş, Uysal M, Gücüyener D, Özdemir G. Parkinson's disease in Eskişehir, Turkey. Eur J Neurol. 1995; 2 (suppl. 1): 44-45.
  3. Horstink M, Tolosa E, Bonuccelli U, et al. Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease. Eur J Neurol. 2006; 13(11): 1170-1185.
  4. Mizuno Y, Takubo H, Mizuta E, Kuno S. Malignant syndrome in Parkinson's disease: concept and review of the literature. Parkinsonism Related Disord 2003; 9:S3-S9. Lieb K, Selim M. Preoperative evaluation of patients with neurological disease. Semin Neurol. 2008; 28:603--10. 4. Robert K.Stoelting, Simon C.Hiller. Drugs Used for Treatment of Parkinson Disease. In:Robert KS, Simon CH, editors. Pharmacology and Physiology in Anesthethic Practice. 4 th ed. Philadelphia: Lippincott Williams and Wilkins;2006: 580-4
  5. Yamamoto T, Tamura N. Autonomic features in Parkinson disease. Review. Japanese. Brain Nerve. 2012 Apr; 64(4):394-402.
  6. Baranov D, Kelton T, McClung H et all. Neurologic disease. In: Anesthesia and uncommon diseases. Fleisher LA (editor), 5th edition; Saunders (Elsevier) USA 2006; 262-64.
  7. Paladını CA, Celada P, Tepper JM. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA (A) receptors in vivo. Neuroscience 1999; 89:799±812. Tenn CC, Nıles LP. Central-type benzodiazepine receptors mediate the antidopaminergic e.ect of clonazepam and melatonin in 6-hydroxydopamine lesioned rats: involvement of a GABAergic mechanism. J Pharmacol Exp Ther 1995; 274(1):84-9
  8. Van de Vijver DAMC, Roos RAC, Jansen PAF, Porsius AJ, de Boer A. Infuence of benzodiazepines on antiparkinsonian drug treatment in levodopa users. Acta Neurol Scand. 2002; 105(1): 8-12.
  9. Shaikh SI, Verna H: Parkinson's disease and anaesthesia. Indian J Anaesth 2011; 55(3):228-234.
  10. Dierdorf SF, Walton JS. Anaesthesia for patients with rare and coexisting disease. In:Clinical anesthesia. Barash PG, Cullen BF, Stoelting RK (Editors), 5th edition;Philadelphia:Lippincott (Williams&Wilkins) 2006: pp 513-14.